{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444539972
| IUPAC_name = [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-<br>diazinan-1-yl)propan-2-yl] carbamate
| image = Febarbamate.svg

<!--Clinical data-->
| tradename = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 13246-02-1
| ATC_prefix = M03
| ATC_suffix = BA05
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104283
| PubChem = 25803
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 24039
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5Z48ONN38P
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07275
| synonyms = MS-543

<!--Chemical data-->
| C = 20 | H = 27 | N = 3 | O = 6 
| molecular_weight = 405.445 g/mol
| smiles = C1(=O)NC(C(C(=O)N1CC(OC(=O)N)COCCCC)(C2=CC=CC=C2)CC)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QHZQILHUJDRDAI-UHFFFAOYSA-N
}}

'''Febarbamate''' ([[International Nonproprietary Name|INN]]; '''Solium''', '''Tymium'''), also known as '''phenobamate''', is an [[anxiolytic]] and [[tranquilizer]] of the [[barbiturate]] and [[carbamate]] families which is used in Europe by itself and as part of a [[combination drug]] [[drug formulation|formulation]] called [[tetrabamate]].<ref name="WHO2004">{{cite web | url = http://whqlibdoc.who.int/hq/2004/WHO_EDM_QSM_2004.5.pdf | author = World Health Organization | title = The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance | year = 2004 | format = PDF}}</ref><ref name="Index nominum 2000: international drug directory">{{cite book | title = Index nominum 2000: international drug directory | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA333 | accessdate = 26 November 2011 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | page = 427}}</ref><ref name="pmid5016064">{{cite journal | author = Gentili E | title = [Therapeutic effects of a new psycholeptic agent (febarbamate, Solium) in pediatrics] | language = Italian | journal = Minerva Medica | volume = 63 | issue = 18 | pages = 1058â€“60 |date=March 1972 | pmid = 5016064 | doi = | url = }}</ref><ref name="MortonMorton1999">{{cite book | vauthors = Morton I, Hall JM| title = Concise dictionary of pharmacological agents: properties and synonyms | url = https://books.google.com/books?id=mqaOMOtk61IC&pg=PA118 | accessdate = 26 November 2011 | year = 1999 | publisher = Springer | isbn = 978-0-7514-0499-9 | pages = 118}}</ref>

== See also ==
* [[Difebarbamate]]

== References ==
{{Reflist}}

{{Muscle relaxants}}
{{Sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:Carbamates]]
[[Category:Muscle relaxants]]
[[Category:Pyrimidines]]
[[Category:Sedatives]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Anxiolytics]]

{{musculoskeletal-drug-stub}}